Diagnostic Test Development and Production for Emergency Response
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75D301-25-R-73207 | Diagnostic Test Development and Production for Emergency Response | |
| Synopsis | ||
|
*******Amendment 0002******** The purpose of this amendment is to provide answers to questions submitted by prospective vendors. ********Amendment 0001******** The purpose of this amendment is to provide answers to questions submitted by prospective vendors and extend the solicitation due date. The Contractor shall provide all labor, materials and equipment using current infrastructure and in-house logistics. The CDC will provide all available data on the pathogen genome sequence, primer/probe sequences or recommended targets, specimen type and biosafety guidance for handling specimens. Inactivated validation specimens or inactivated genomic material for use in generating artificial validation specimens .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| CENTERS FOR DISEASE CONTROL AND PREVENTION | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75D301-25-R-73207 | Diagnostic Test Development and Production for Emergency Response | |
| Synopsis | ||
|
********Amendment 0001******** The purpose of this amendment is to provide answers to questions submitted by prospective vendors and extend the solicitation due date. The Contractor shall provide all labor, materials and equipment using current infrastructure and in-house logistics. The CDC will provide all available data on the pathogen genome sequence, primer/probe sequences or recommended targets, specimen type and biosafety guidance for handling specimens. Inactivated validation specimens or inactivated genomic material for use in generating artificial validation specimens may be provided if available. One or more of the following tasks will be utilized within task orders .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| CENTERS FOR DISEASE CONTROL AND PREVENTION | Combined Synopsis/Solicitation | |
| SetAside Type | ||
| Solicitation ID | Solicitation Title | Solicitation Office |
| 75D301-25-R-73207 | Diagnostic Test Development and Production for Emergency Response | |
| Synopsis | ||
|
The Contractor shall provide all labor, materials and equipment using current infrastructure and in-house logistics. The CDC will provide all available data on the pathogen genome sequence, primer/probe sequences or recommended targets, specimen type and biosafety guidance for handling specimens. Inactivated validation specimens or inactivated genomic material for use in generating artificial validation specimens may be provided if available. One or more of the following tasks will be utilized within task orders developed under the IDIQ contract: Task 1: In collaboration with the CDC, develop a plan for the rapid development and validation of Nucleic Acid Amplification Tests .... Read More |
||
| Office Location | Agency Name | Solicitation Base Posting Type |
| CENTERS FOR DISEASE CONTROL AND PREVENTION | Combined Synopsis/Solicitation | |
